Literature DB >> 7608718

Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease.

O Bandmann1, M B Davis, C D Marsden, A E Harding.   

Abstract

Mutations in the superoxide dismutase 1 (SOD1) gene have been detected in affected members of some families with familial amyotrophic lateral sclerosis. To evaluate the possibility of a shared genetic defect in amyotrophic lateral sclerosis and Parkinson's disease, the SOD1 gene was sequenced in index patients with familial Parkinson's disease from 23 families. No changes were detected.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7608718      PMCID： PMC1073609          DOI： 10.1136/jnnp.59.1.90

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  17 in total

Review 1.  Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.

Authors:  A Eisen; D Calne
Journal:  Can J Neurol Sci       Date:  1992-02       Impact factor: 2.104

2.  Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility.

Authors:  D Majoor-Krakauer; R Ottman; W G Johnson; L P Rowland
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

3.  Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.

Authors:  V Planté-Bordeneuve; M B Davis; D M Maraganore; C D Marsden; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

4.  Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.

Authors:  D R Borchelt; M K Lee; H S Slunt; M Guarnieri; Z S Xu; P C Wong; R H Brown; D L Price; S S Sisodia; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

5.  Mutant debrisoquine hydroxylation genes in Parkinson's disease.

Authors:  M Armstrong; A K Daly; S Cholerton; D N Bateman; J R Idle
Journal:  Lancet       Date:  1992-04-25       Impact factor: 79.321

6.  A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.

Authors:  H Saggu; J Cooksey; D Dexter; F R Wells; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-09       Impact factor: 5.372

Review 7.  Oxidative damage in neurodegenerative disease.

Authors:  P Jenner
Journal:  Lancet       Date:  1994-09-17       Impact factor: 79.321

8.  Increased risk of Parkinson's disease in parents and siblings of patients.

Authors:  H Payami; K Larsen; S Bernard; J Nutt
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422

9.  Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus.

Authors:  R J Marttila; H Lorentz; U K Rinne
Journal:  J Neurol Sci       Date:  1988-09       Impact factor: 3.181

10.  Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis.

Authors:  A Pramatarova; D A Figlewicz; A Krizus; F Y Han; I Ceballos-Picot; A Nicole; M Dib; V Meininger; R H Brown; G A Rouleau
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025
View more
  1 in total

1.  Proteome analysis of human substantia nigra in Parkinson's disease.

Authors:  Cornelius J Werner; Roland Heyny-von Haussen; Gerhard Mall; Sabine Wolf
Journal:  Proteome Sci       Date:  2008-02-14       Impact factor: 2.480
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.